Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 16, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Solid Tumor, Adult
Interventions
DRUG

Topical application of a fluorescent imaging agent

"The fluorescent imaging agent will be topically applied only onto the resection planes of the freshly resected tumor specimen.~During incubation and after each washing steps, visible light and fluorescent overlay images will be acquired using a fluorescence sensitive camera system."

Trial Locations (1)

3015 GD

RECRUITING

Erasmus University Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER

NCT06292845 - Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents | Biotech Hunter | Biotech Hunter